Showing results (121-130 of 175) with videos related to
Sort By:
Pageof 18
Journal of Affective Disorders|August 14, 2013
Measuring depressive symptoms using the Patient Health Questionnaire-9 in Hong Kong Chinese subjects with type 2 diabetesYuying Zhang, Rose Ting, Marco Lam, et al.Diabetes, Obesity & Metabolism|March 15, 2019
Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trialWenying Yang, Jianhua Ma, Tianpei Hong, et al.Nature Communications|June 24, 2022
A phase 1b randomised controlled trial of a glucagon-like peptide-1 and glucagon receptor dual agonist IBI362 (LY3305677) in Chinese patients with type 2 diabetesHongwei Jiang, Shuguang Pang, Yawei Zhang, et al.Plos One|June 19, 2013
Prevalence of hypertension in china: a cross-sectional studyYun Gao, Gang Chen, Haoming Tian, et al.Zhonghua Nei Ke Za Zhi|April 17, 2015
[Effect of lifestyle interventions on reduction of cardiovascular disease events and its mortality in pre-diabetic patients:long-term follow-up of Da Qing Diabetes Prevention Study]Yanyan Chen, Jinping Wang, Yali An, et al.Endocrine Journal|September 10, 2020
Gender-differential effects on blood glucose levels between acarbose and metformin in Chinese patients with newly diagnosed type 2 diabetes: a sub-analysis of the MARCH trialJianxin Li, Jing Li, Zhongyan Shan, et al.Diabetes Research and Clinical Practice|June 1, 2016
Relationship between glycated albumin and glycated hemoglobin according to glucose tolerance status: A multicenter studyYifei Mo, Xiaojing Ma, Hong Li, et al.Chinese Medical Journal|January 21, 2014
Biphasic insulin aspart 30 improved glycemic control in Chinese patients with type 2 diabetes poorly controlled on oral glucose-lowering drugs: a subgroup analysis of the A₁chieve studyLiming Chen, Xiaoyan Xing, Minxiang Lei, et al.Journal of Diabetes|December 14, 2022
Yogliptin monotherapy in type 2 diabetes: A 12-week randomized, double-blind, placebo-controlled phase II studyXin Wang, Ying Wang, Xiaolan Yong, et al.Journal of Diabetes Investigation|January 28, 2016
Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trialWenying Yang, Lvyun Zhu, Bangzhu Meng, et al.Pageof 18